Tag: David Ricks

October 12, 2015 Off

Eli Lilly: Evacetrapib Phase 3 trial terminated

Eli Lilly and Company and the ACCELERATE study’s academic leadership have accepted the recommendation of the independent data monitoring committee to terminate the Phase 3 trial of the investigational medicine evacetrapib, due to insufficient efficacy.

October 7, 2015 Off

Lilly Joins the Imaging Dementia – Evidence for Amyloid Scanning (IDEAS) Study

By Dino Mustafić

Eli Lilly and Company and Avid Radiopharmaceuticals, Inc., a wholly owned subsidiary of Lilly, have announced financial commitment and continued scientific partnership to support the recently established Imaging Dementia – Evidence for Amyloid Scanning (IDEAS) Study.